These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11294506)

  • 21. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
    Fenouillet E; Clerget-Raslain B; Gluckman JC; Guétard D; Montagnier L; Bahraoui E
    J Exp Med; 1989 Mar; 169(3):807-22. PubMed ID: 2538547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
    Witvrouw M; Fikkert V; Hantson A; Pannecouque C; O'keefe BR; McMahon J; Stamatatos L; de Clercq E; Bolmstedt A
    J Virol; 2005 Jun; 79(12):7777-84. PubMed ID: 15919930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane bound Indian clade C HIV-1 envelope antigen induces antibodies to diverse and conserved epitopes upon DNA prime/protein boost in rabbits.
    Rangasamy SP; Menon V; Dhopeshwarkar P; Pal R; Vaniambadi KS; Mahalingam S
    Vaccine; 2016 May; 34(21):2444-2452. PubMed ID: 27032514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant glycoprotein vaccines for human immunodeficiency virus-infected children and their effects on viral quasispecies.
    Essajee SM; Yogev R; Pollack H; Greenhouse B; Krasinski K; Borkowsky W
    Clin Diagn Lab Immunol; 2002 Jan; 9(1):79-82. PubMed ID: 11777833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of HIV-1-specific neutralizing antibodies in mice vaccinated with a recombinant Sendai virus vector.
    Kano M; Matano T; Kato A; Shioda T; Nagai Y
    Jpn J Infect Dis; 2002 Apr; 55(2):59-60. PubMed ID: 12082313
    [No Abstract]   [Full Text] [Related]  

  • 26. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
    Shinoda K; Xin KQ; Kojima Y; Saha S; Okuda K; Okuda K
    Clin Immunol; 2006 Apr; 119(1):32-7. PubMed ID: 16458074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.
    Go EP; Herschhorn A; Gu C; Castillo-Menendez L; Zhang S; Mao Y; Chen H; Ding H; Wakefield JK; Hua D; Liao HX; Kappes JC; Sodroski J; Desaire H
    J Virol; 2015 Aug; 89(16):8245-57. PubMed ID: 26018173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of the transmembrane domain of HIV-1 envelope glycoprotein.
    Chen B; Chou JJ
    FEBS J; 2017 Apr; 284(8):1171-1177. PubMed ID: 27868386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity.
    Sjölander S; Bolmstedt A; Akerblom L; Horal P; Olofsson S; Morein B; Sjölander A
    Virology; 1996 Jan; 215(2):124-33. PubMed ID: 8560759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simplified procedure for fractionation and structural characterisation of complex mixtures of N-linked glycans, released from HIV-1 gp120 and other highly glycosylated viral proteins.
    Biller M; Bolmstedt A; Hemming A; Olofsson S
    J Virol Methods; 1998 Dec; 76(1-2):87-100. PubMed ID: 9923743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-depth characterization of protein N-glycosylation for a COVID-19 variant-design vaccine spike protein.
    Huang J; Hou S; An J; Zhou C
    Anal Bioanal Chem; 2023 Mar; 415(8):1455-1464. PubMed ID: 36698045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
    Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
    J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network.
    Gorse GJ; Frey SE; Patel G; Newman FK; Belshe RB
    Vaccine; 1994 Aug; 12(10):912-8. PubMed ID: 7975833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers.
    Go EP; Ding H; Zhang S; Ringe RP; Nicely N; Hua D; Steinbock RT; Golabek M; Alin J; Alam SM; Cupo A; Haynes BF; Kappes JC; Moore JP; Sodroski JG; Desaire H
    J Virol; 2017 May; 91(9):. PubMed ID: 28202756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of orthogonal chromatographic and lectin-affinity microarray methods for glycan profiling of a therapeutic monoclonal antibody.
    Cook MC; Kaldas SJ; Muradia G; Rosu-Myles M; Kunkel JP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 997():162-78. PubMed ID: 26114652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunogenicity of plasmid DNA and adenoviral vectors encoding HIV-1 subtype B env gene].
    Yang HR; Zhang LF; Feng X; Yu SQ; Zhuang ZL; Li HX; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):415-7. PubMed ID: 21604562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Online nanoliquid chromatography-mass spectrometry and nanofluorescence detection for high-resolution quantitative N-glycan analysis.
    Kalay H; Ambrosini M; van Berkel PH; Parren PW; van Kooyk Y; García Vallejo JJ
    Anal Biochem; 2012 Apr; 423(1):153-62. PubMed ID: 22330744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-glycosylation profile of recombinant human soluble Fcgamma receptor III.
    Takahashi N; Cohen-Solal J; Galinha A; Fridman WH; Sautès-Fridman C; Kato K
    Glycobiology; 2002 Aug; 12(8):507-15. PubMed ID: 12145191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphoproliferative response to synthetic V3 loop P18 peptide and HIV-1 envelope glycoprotein among individuals immunized with gp160 candidate vaccines.
    Moukrim Z; Cho YY; Mbika JP; Achour A
    Biomed Pharmacother; 1996; 50(10):494-9. PubMed ID: 9091063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.